Neurobo Pharmaceuticals Stock Market Value

NRBO Stock  USD 4.11  0.03  0.74%   
Neurobo Pharmaceuticals' market value is the price at which a share of Neurobo Pharmaceuticals trades on a public exchange. It measures the collective expectations of Neurobo Pharmaceuticals investors about its performance. Neurobo Pharmaceuticals is selling at 4.11 as of the 25th of June 2024; that is 0.74 percent up since the beginning of the trading day. The stock's open price was 4.08.
With this module, you can estimate the performance of a buy and hold strategy of Neurobo Pharmaceuticals and determine expected loss or profit from investing in Neurobo Pharmaceuticals over a given investment horizon. Check out Neurobo Pharmaceuticals Correlation, Neurobo Pharmaceuticals Volatility and Neurobo Pharmaceuticals Alpha and Beta module to complement your research on Neurobo Pharmaceuticals.
To learn how to invest in Neurobo Stock, please use our How to Invest in Neurobo Pharmaceuticals guide.
Symbol

Neurobo Pharmaceuticals Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurobo Pharmaceuticals. If investors know Neurobo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurobo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.3
Return On Assets
(0.52)
Return On Equity
(1.08)
The market value of Neurobo Pharmaceuticals is measured differently than its book value, which is the value of Neurobo that is recorded on the company's balance sheet. Investors also form their own opinion of Neurobo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Neurobo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurobo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Neurobo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurobo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurobo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurobo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Neurobo Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neurobo Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neurobo Pharmaceuticals.
0.00
07/06/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
06/25/2024
0.00
If you would invest  0.00  in Neurobo Pharmaceuticals on July 6, 2022 and sell it all today you would earn a total of 0.00 from holding Neurobo Pharmaceuticals or generate 0.0% return on investment in Neurobo Pharmaceuticals over 720 days. Neurobo Pharmaceuticals is related to or competes with Allarity Therapeutics, Virax Biolabs, Quoin Pharmaceuticals, Biodexa Pharmaceticals, Zura Bio, Phio Pharmaceuticals, and Sonnet Biotherapeutics. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal diseas... More

Neurobo Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neurobo Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neurobo Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Neurobo Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Neurobo Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neurobo Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Neurobo Pharmaceuticals historical prices to predict the future Neurobo Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neurobo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.354.117.87
Details
Intrinsic
Valuation
LowRealHigh
1.034.798.55
Details
2 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.69-0.61-0.49
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Neurobo Pharmaceuticals. Your research has to be compared to or analyzed against Neurobo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Neurobo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Neurobo Pharmaceuticals.

Neurobo Pharmaceuticals Backtested Returns

Neurobo Pharmaceuticals has Sharpe Ratio of -0.0049, which conveys that the firm had a -0.0049% return per unit of risk over the last 3 months. Neurobo Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neurobo Pharmaceuticals' Mean Deviation of 2.61, standard deviation of 3.71, and Risk Adjusted Performance of 6.0E-4 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.98, which conveys possible diversification benefits within a given portfolio. Neurobo Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Neurobo Pharmaceuticals is expected to follow. At this point, Neurobo Pharmaceuticals has a negative expected return of -0.0183%. Please make sure to verify Neurobo Pharmaceuticals' treynor ratio and rate of daily change , to decide if Neurobo Pharmaceuticals performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.08  

Very weak reverse predictability

Neurobo Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Neurobo Pharmaceuticals time series from 6th of July 2022 to 1st of July 2023 and 1st of July 2023 to 25th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neurobo Pharmaceuticals price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Neurobo Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient-0.08
Spearman Rank Test-0.05
Residual Average0.0
Price Variance0.4

Neurobo Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Neurobo Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neurobo Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Neurobo Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Neurobo Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Neurobo Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neurobo Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neurobo Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neurobo Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Neurobo Pharmaceuticals Lagged Returns

When evaluating Neurobo Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neurobo Pharmaceuticals stock have on its future price. Neurobo Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neurobo Pharmaceuticals autocorrelation shows the relationship between Neurobo Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Neurobo Pharmaceuticals.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Neurobo Stock

When determining whether Neurobo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurobo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurobo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurobo Pharmaceuticals Stock:
Check out Neurobo Pharmaceuticals Correlation, Neurobo Pharmaceuticals Volatility and Neurobo Pharmaceuticals Alpha and Beta module to complement your research on Neurobo Pharmaceuticals.
To learn how to invest in Neurobo Stock, please use our How to Invest in Neurobo Pharmaceuticals guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Neurobo Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neurobo Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurobo Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...